Tampa, FL, February 24, 2015 — Specialty Pharma Journal (SPJ) announced today that it has partnered with the Specialty Pharma Education Center (SPEC) to bring business-based educational programs to the specialty pharmacy industry.
SPJ and SPEC are developing programs dedicated to education in biosimilars, 340B contracting, co-pay and coupon adjudication guidelines in compliance with the Office of Inspector General (OIG), sales force rep training, health information technology for specialty pharmacy, and patient adherence.
“The specialty market is rapidly evolving. Significant changes lie ahead, with the emergence of biosimilars, precision medicine and health information technology. Our live, educational programs will be sure to educate attendees on all of the new opportunities and key challenges that surround this evolving industry,” said Gary M. Cohen, BSPharm, RPh, CSP, Publisher of Specialty Pharma Journal.
SPEC has nearly 300 hours of accredited education covering specialty topics.
With more than 9,500 subscribers, SPJ reaches the specialty pharmacy industry with daily news updates and editorial related to the specialty pharmaceutical market.
SPJ’s network of healthcare providers in the specialty pharmaceutical industry coupled with SPEC’s expertise in developing educational programs covering specialty topics is intended to serve as a platform to bring in key speakers to the appropriate audience. “By fully understanding the business aspects surrounding healthcare, we can work together to improve patient outcomes,” said Cohen.
For convenience, the business-based educational programs will be held in New York and Washington, DC. The programs will be one-day, live events, which will include speakers who are experts in their field. The dates and detailed agenda have yet to be determined.
Specialty Pharma Journal (SPJ), which was established in 2010, is a free, interactive, online journal, providing news and editorial surrounding the specialty pharmacy industry. With the evolving healthcare industry and the emergence of precision and technology medicine, SPJ is now dedicated to providing timely and relevant news on precision and technology medicine in the specialty industry. With a subscriber base of nearly 10,000 individuals, SPJ reaches multiple stakeholders in the healthcare market with news and information through its e-Newsletters, distributed Monday through Friday, and is expanding its audience reach to include health systems and prescribers. For more information on SPJ, visit: www.specialtypharmajournal.com.
Committed to developing and disseminating live, print, and web-based CE/CME programs, SPEC designs its educational programs to address the identified continuing education needs of healthcare professionals based on industry conducted needs assessments and gap analysis of therapeutic areas in the specialty market, emerging technologies and key healthcare policy/legislation. For more information on SPEC, visit: www.specialtycme.org.